Literature DB >> 20595496

Identification of a hyperendemic area for Trypanosoma cruzi infection in central Veracruz, Mexico.

Angel Ramos-Ligonio1, Aracely López-Monteon, Daniel Guzmán-Gómez, José Luis Rosales-Encina, Yairh Limón-Flores, Eric Dumonteil.   

Abstract

The state of Veracruz, Mexico, is a well-recognized endemic region for Chagas disease, but the geographic distribution of the disease and its magnitude are still poorly documented. We evaluated the seroprevalence of Trypanosoma cruzi infection in the sanitary jurisdictions of Cordoba and Cosamaloapan in central Veracruz. A total of 654 serum samples from 19 rural localities were tested by using four tests: two enzyme-linked immunosorbent assays, an indirect immunofluorescent, and Western blotting. Overall, 110 (16.8%) of 654 samples were positive for T. cruzi by >/= 2 tests (95% confidence interval = 14.2-19.9%). The municipality of Tezonapa in the jurisdiction of Cordoba was identified as a potential hyperendemic region with seroprevalence rates </= 45% in young children. No cases were detected in the jurisdiction of Cosamaloapan. Further studies should help clarify T. cruzi transmission dynamics in Tezonapa. The magnitude of T. cruzi infection rate in this region calls for the urgent implementation of extensive epidemiologic surveillance and control programs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20595496      PMCID: PMC2912594          DOI: 10.4269/ajtmh.2010.09-0677

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  27 in total

1.  High prevalence of congenital Trypanosoma cruzi infection and family clustering in Salta, Argentina.

Authors:  Olga Sánchez Negrette; María Celia Mora; Miguel Angel Basombrío
Journal:  Pediatrics       Date:  2005-06       Impact factor: 7.124

Review 2.  Chagas disease in Mexico: an analysis of geographical distribution during the past 76 years--a review.

Authors:  Alejandro Cruz-Reyes; José Miguel Pickering-López
Journal:  Mem Inst Oswaldo Cruz       Date:  2006-06       Impact factor: 2.743

3.  Chagas disease in an area of recent occupation in Cochabamba, Bolivia.

Authors:  H Albarracin-Veizaga; M E de Carvalho; E M Nascimento; V L Rodrigues; C Casanova; J M Barata
Journal:  Rev Saude Publica       Date:  1999-06       Impact factor: 2.106

4.  Serological and parasitological screening of Trypanosoma cruzi infection in mothers and newborns living in two Chagasic areas of Mexico.

Authors:  Amonario Olivera Mar; Fernando Guillén Ortega; Salatiel Cruz Vidal; Nidia Hernández-Becerril; Enrique Pérez Galdamez; Guzmán Córdova Concepción; Pedro A Reyes; Victor M Monteón
Journal:  Arch Med Res       Date:  2006-08       Impact factor: 2.235

Review 5.  Triatoma dimidiata (Latreille, 1811): a review of its diversity across its geographic range and the relationship among populations.

Authors:  Patricia L Dorn; Carlota Monroy; Andrew Curtis
Journal:  Infect Genet Evol       Date:  2006-11-13       Impact factor: 3.342

6.  [Chronic Chagasic Cardiomyopathy at the Hospital General de Zona no. 24 IMSS. Poza Rica, Veracruz].

Authors:  Amonario Olivera-Mar; Catalina Hernández-Vicencio; Margarita Camacho-Marie; Nidia Hernández-Becerril; Víctor M Monteón-Padilla; Maite Vallejo; Pedro A Reyes
Journal:  Arch Cardiol Mex       Date:  2006 Jul-Sep

7.  Sustainable vector control and management of Chagas disease in the Gran Chaco, Argentina.

Authors:  Ricardo E Gürtler; Uriel Kitron; M Carla Cecere; Elsa L Segura; Joel E Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-03       Impact factor: 11.205

8.  [Seroprevalence of Trypanosoma cruzi antibodies and associated risk factors among the population under 18 years of age in Veracruz, Mexico].

Authors:  Paz María Salazar; Gloria Rojas; Martha Bucio; Margarita Cabrera; Guadalupe García; Adela Ruiz; Yolanda Guevara; Roberto Tapia
Journal:  Rev Panam Salud Publica       Date:  2007-08

9.  [Prevalence of antibodies against Trypanosoma cruzi in blood bank donors from the IMSS General Hospital in Orizaba, Veracruz, Mexico].

Authors:  Angel Ramos-Ligonio; Michaía Elián Ramírez-Sánchez; Juan Carlos González-Hernández; José Luis Rosales-Encina; Aracely López-Monteon
Journal:  Salud Publica Mex       Date:  2006 Jan-Feb

10.  Mother-to-child transmission of Chagas' disease in North America: why don't we do more?

Authors:  Pierre Buekens; Olivia Almendares; Yves Carlier; Eric Dumonteil; Mark Eberhard; Rubi Gamboa-Leon; Mark James; Nicolas Padilla; Dawn Wesson; Xu Xiong
Journal:  Matern Child Health J       Date:  2007-06-30
View more
  11 in total

1.  Presence of Seropositive Patients to Trypanosoma cruzi in a Municipality of the Mixtec Sierra of the State of Puebla: A Preliminary Study.

Authors:  L Zumaquero-Ríos; J Sarracent-Pérez; C Sandoval-Ruiz; R M Aldana-Arnas; A López-Monteon; J Torres-Montero; D Guzmán-Gómez; A Ramos-Ligonio
Journal:  Acta Parasitol       Date:  2019-09-30       Impact factor: 1.440

2.  High frequency of human blood in Triatoma dimidiata captured inside dwellings in a rural community in the Yucatan Peninsula, Mexico, but low antibody seroprevalence and electrocardiographic findings compatible with Chagas disease in humans.

Authors:  Victor Monteon; César Alducin; Jorge Hernández; Angel Ramos-Ligonio; Ruth Lopez
Journal:  Am J Trop Med Hyg       Date:  2013-01-07       Impact factor: 2.345

3.  House infestation dynamics and feeding sources of Triatoma dimidiata in central Veracruz, Mexico.

Authors:  Jesús Torres-Montero; Aracely López-Monteon; Eric Dumonteil; Angel Ramos-Ligonio
Journal:  Am J Trop Med Hyg       Date:  2012-04       Impact factor: 2.345

4.  Presence of Anti-T. cruzi Antibodies in Inhabitants and Dogs of Two Rural Settlements in the Sierra de Los Tuxtlas, Veracruz, Mexico.

Authors:  G E Benítez-Villa; A López-Monteon; E Waleckx; E Dumonteil; A J Márquez-Fernández; M J Rovirosa-Hernández; F Orduña-García; D Guzmán-Gómez; A Ramos-Ligonio
Journal:  Acta Parasitol       Date:  2022-05-10       Impact factor: 1.534

Review 5.  Accelerating the development of a therapeutic vaccine for human Chagas disease: rationale and prospects.

Authors:  Eric Dumonteil; Maria Elena Bottazzi; Peter J Hotez; Bin Zhan; Michael J Heffernan; Kathryn Jones; Jesus G Valenzuela; Shaden Kamhawi; Jaime Ortega; Samuel Ponce de Leon Rosales; Bruce Y Lee; Kristina M Bacon; Bernhard Fleischer; B T Slingsby; Miguel Betancourt Cravioto; Roberto Tapia-Conyer
Journal:  Expert Rev Vaccines       Date:  2012-09       Impact factor: 5.217

6.  Trypanosoma cruzi: seroprevalence detection in suburban population of Santiago de Querétaro (Mexico).

Authors:  Ángeles López-Céspedes; Elena Villagrán; Kervin Briceño Álvarez; José Antonio de Diego; Hebert Luís Hernández-Montiel; Carlos Saldaña; Manuel Sānchez-Moreno; Clotilde Marín
Journal:  ScientificWorldJournal       Date:  2012-05-03

7.  Intrusive versus domiciliated triatomines and the challenge of adapting vector control practices against Chagas disease.

Authors:  Etienne Waleckx; Sébastien Gourbière; Eric Dumonteil
Journal:  Mem Inst Oswaldo Cruz       Date:  2015-03-14       Impact factor: 2.743

Review 8.  An unfolding tragedy of Chagas disease in North America.

Authors:  Peter J Hotez; Eric Dumonteil; Miguel Betancourt Cravioto; Maria Elena Bottazzi; Roberto Tapia-Conyer; Sheba Meymandi; Unni Karunakara; Isabela Ribeiro; Rachel M Cohen; Bernard Pecoul
Journal:  PLoS Negl Trop Dis       Date:  2013-10-31

9.  Highly discordant serology against Trypanosoma cruzi in central Veracruz, Mexico: role of the antigen used for diagnostic.

Authors:  Daniel Guzmán-Gómez; Aracely López-Monteon; María de la Soledad Lagunes-Castro; Carolina Álvarez-Martínez; Manuel Jesús Hernández-Lutzon; Eric Dumonteil; Angel Ramos-Ligonio
Journal:  Parasit Vectors       Date:  2015-09-17       Impact factor: 3.876

10.  Association of Trypanosoma cruzi infection with risk factors and electrocardiographic abnormalities in northeast Mexico.

Authors:  Zinnia Judith Molina-Garza; José Luis Rosales-Encina; Roberto Mercado-Hernández; Daniel P Molina-Garza; Ricardo Gomez-Flores; Lucio Galaviz-Silva
Journal:  BMC Infect Dis       Date:  2014-03-01       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.